AINDEX
Markets

Edwards Lifesciences Corporation (EW)

EWNYSEIndustrial Specialties

$103.59

-1.12 (-1.07%) today

Regular session, Nov 10, 3:01 PM ET

-1.07% 1D
Market cap
$59.56bn
P/E
35.2
EPS, last 4 quarters
$2.94
Dividend yield
–
Day range
$102.43 to $104.58
52-week range
$74.66 to $105.37
Average volume
2.72m
Previous close
$104.71

Analysts

22 covering

Buy20 buy, 2 hold, 0 sell

Targets a year out average $114.30, +10.3% from here

$97.00now $103.59$125.00

Earnings

next estimate $0.6600

Next report

Dec 2025

-6.5%

Mar 2026

+4.0%

Jun 2026

+6.8%

Sep 2026

+9.6%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.57bn$1.65bn$1.74bn$1.72bn
Gross profit$1.23bn$1.29bn$1.35bn$1.35bn
Operating income$151.10m$477.60m$513.20m$299.10m
Net income$91.20m$380.70m$241.90m$307.50m

Last four quarters: revenue $6.67bn, margin 15.3%, free cash flow $1.42bn

News

8 latest

The company

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most.

Sector
Health Care
Industry
Industrial Specialties
Exchange
NYSE
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.